Cargando…

Mesenchymal stem cell use in acute respiratory distress syndrome: a potential therapeutic application

Acute respiratory distress syndrome (ARDS) is a condition of acute respiratory failure resulting from noncardiogenic pulmonary edema. It may occur as a consequence of lung infection, sepsis, trauma, aspiration or drug reaction. The pathogenesis of ARDS is understood to be an unregulated inflammatory...

Descripción completa

Detalles Bibliográficos
Autores principales:	Freitag, Julien, Wickham, James, Shah, Kiran, Tenen, Abi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Science Ltd 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351095/ https://www.ncbi.nlm.nih.gov/pubmed/32670609 http://dx.doi.org/10.2144/fsoa-2020-0048

Ejemplares similares

Effect of autologous adipose-derived mesenchymal stem cell therapy in the treatment of acromioclavicular joint osteoarthritis
por: Freitag, Julien, et al.
Publicado: (2019)

Effect of autologous adipose-derived mesenchymal stem cell therapy in the treatment of an osteochondral lesion of the ankle
por: Freitag, Julien, et al.
Publicado: (2020)

Effect of autologous adipose-derived mesenchymal stem cell therapy in combination with autologous platelet-rich plasma in the treatment of elbow tendinopathy
por: Freitag, Julien, et al.
Publicado: (2020)

Effect of autologous adipose-derived mesenchymal stem cell therapy in the treatment of a post-traumatic chondral defect of the knee
por: Freitag, Julien, et al.
Publicado: (2017)

High tibial osteotomy in combination with arthroscopic abrasion arthroplasty and autologous adipose-derived mesenchymal stem cell therapy in the treatment of advanced knee osteoarthritis
por: Freitag, Julien, et al.
Publicado: (2019)

The effect of autologous adipose derived mesenchymal stem cell therapy in the treatment of a large osteochondral defect of the knee following unsuccessful surgical intervention of osteochondritis dissecans – a case study
por: Freitag, Julien, et al.
Publicado: (2017)

Mesenchymal stem cell therapy in the treatment of osteoarthritis: reparative pathways, safety and efficacy – a review
por: Freitag, Julien, et al.
Publicado: (2016)

Therapeutic Benefits of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome: Potential Mechanisms and Challenges
por: Cao, Chao, et al.
Publicado: (2022)

Therapeutic implications of mesenchymal stem cells in acute lung injury/acute respiratory distress syndrome
por: Wang, Yan-Yang, et al.
Publicado: (2013)

Current understanding of the therapeutic benefits of mesenchymal stem cells in acute respiratory distress syndrome
por: Lopes-Pacheco, Miquéias, et al.
Publicado: (2019)

Therapeutic mechanisms of mesenchymal stem cells in acute respiratory distress syndrome reveal potentials for Covid-19 treatment
por: Wang, Wendi, et al.
Publicado: (2021)

Mesenchymal Stem Cells Represent a Potential Therapeutic Option for Coronavirus Disease 2019-Related Acute Respiratory Distress Syndrome
por: Zhao, Xuan, et al.
Publicado: (2020)

Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome
por: Harrell, Carl Randall, et al.
Publicado: (2020)

RUNX1 mediates the therapeutic effects of mesenchymal stem cells‐derived microparticles in acute respiratory distress syndrome
por: Predescu, Dan, et al.
Publicado: (2023)

Mesenchymal stem cells - a promising therapy for Acute Respiratory Distress Syndrome
por: Hayes, Mairead, et al.
Publicado: (2012)

Genetically modified mesenchymal stem cell therapy for acute respiratory distress syndrome
por: Han, Jibin, et al.
Publicado: (2019)

Current status and prospects of basic research and clinical application of mesenchymal stem cells in acute respiratory distress syndrome
por: Liang, Tian-Yu, et al.
Publicado: (2023)

Mesenchymal Stem Cells Reconditioned in Their Own Serum Exhibit Augmented Therapeutic Properties in the Setting of Acute Respiratory Distress Syndrome
por: Xu, Amy L., et al.
Publicado: (2019)

Recent insights: mesenchymal stromal/stem cell therapy for acute respiratory distress syndrome
por: Horie, Shahd, et al.
Publicado: (2016)

The effect of acute respiratory distress syndrome on bone marrow-derived mesenchymal stem cells
por: Antebi, Ben, et al.
Publicado: (2018)

Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics
por: Qin, Hua, et al.
Publicado: (2020)

Strategies to Enhance Mesenchymal Stem Cell-Based Therapies for Acute Respiratory Distress Syndrome
por: Han, Jibin, et al.
Publicado: (2019)

Mesenchymal stem cell‐derived extracellular vesicles for the treatment of acute respiratory distress syndrome
por: Abraham, Aswin, et al.
Publicado: (2019)

Mesenchymal Stem Cell: Does it Work in an Experimental Model with Acute Respiratory Distress Syndrome?
por: Yilmaz, Sema, et al.
Publicado: (2012)

Mesenchymal stem cells-derived extracellular vesicles in acute respiratory distress syndrome: a review of current literature and potential future treatment options
por: Shah, Trushil G., et al.
Publicado: (2019)

Differentiation Potential of Early- and Late-Passage Adipose-Derived Mesenchymal Stem Cells Cultured under Hypoxia and Normoxia
por: Zhao, Ashley G., et al.
Publicado: (2020)

Mesenchymal stromal cell application as an emerging translational medicine for acute respiratory distress syndrome
por: Lee, Hyun Jung, et al.
Publicado: (2020)

Mesenchymal Stem Cell–derived Exosomes: Are They Another Therapeutic Method for Extracorporeal Membrane Oxygenation–supported Acute Respiratory Distress Syndrome?
por: Zhang, Lanyu, et al.
Publicado: (2020)

Overexpression of FoxM1 optimizes the therapeutic effect of bone marrow mesenchymal stem cells on acute respiratory distress syndrome
por: Luo, Yuling, et al.
Publicado: (2023)

Extracellular Vesicles Derived from Mesenchymal Stem Cells: A Potential Biodrug for Acute Respiratory Distress Syndrome Treatment
por: Sun, Hao, et al.
Publicado: (2022)

Identification of potential biomarkers and therapeutic targets for posttraumatic acute respiratory distress syndrome
por: Qi, Peng, et al.
Publicado: (2023)

Rationale for the Use of Radiation-Activated Mesenchymal Stromal/Stem Cells in Acute Respiratory Distress Syndrome
por: Tovar, Isabel, et al.
Publicado: (2020)

Acute Respiratory Distress Syndrome: Pathophysiology and Therapeutic Options
por: Pierrakos, Charalampos, et al.
Publicado: (2012)

RNAi therapeutic strategies for acute respiratory distress syndrome
por: Jagrosse, Melissa L., et al.
Publicado: (2019)

Mesenchymal Stem Cell-Derived Extracellular Vesicles and Their Therapeutic Potential
por: Zhao, Ashley G., et al.
Publicado: (2020)

Mesenchymal Stem Cells for the Compassionate Treatment of Severe Acute Respiratory Distress Syndrome Due to COVID 19
por: Iglesias, Martin, et al.
Publicado: (2021)

Viral Pneumonia and Acute Respiratory Distress Syndrome
por: Shah, Raj D., et al.
Publicado: (2017)

Application of clinical proteomics in acute respiratory distress syndrome
por: Bhargava, Maneesh, et al.
Publicado: (2014)

Using Dictyostelium to Develop Therapeutics for Acute Respiratory Distress Syndrome
por: Kirolos, Sara A., et al.
Publicado: (2021)

Therapeutic targeting of metabolic alterations in acute respiratory distress syndrome
por: Robinson, Matthew John, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0n3dvvsd9r6rs773pkfdduhu25